Dynorphin, stress, and depression-Reference-Cited by-同舟云学术

Dynorphin, stress, and depression

Published:2010-02 Issue: Volume:1314 Page:56-73
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Knoll Allison T.,Carlezon William A.

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference226 articles.

1. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex;Abercrombie;J. Neurochem.,1989

2. Long-term effects of brief acute stress on cellular signaling and hippocampal LTP;Ahmed;J. Neurosci.,2006

3. Peptide kappa opioid receptor ligands: potential for drug development;Aldrich;Aaps. J.,2009

4. Extended amygdala and basal forebrain;Alheid;Ann. N.Y. Acad. Sci.,2003

5. American Psychiatric Association DSM-IV-TR (2000) Diagnostic and statistical manual of mental disorders, 4th ed., text revision edition. Washington, DC.

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence;Pharmacology Biochemistry and Behavior;2024-10

2. Discovery of N′-benzyl-3-chloro-N-((1S,3R,4R)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)cyclohexyl)benzenesulfonamide as a novel selective KOR ligand;European Journal of Medicinal Chemistry;2024-10

3. Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse;Neuropharmacology;2024-10

4. Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile;Bioorganic Chemistry;2024-07

5. Neuromodulation of safety and surprise in the early stages of infant development: affective homeostatic regulation in bodily and mental functions;Frontiers in Psychology;2024-06-06